Clik here to view.
Indecent Disclosure: The Press Release Balancing Act
Sometimes it’s tough for biotechs to figure out what, exactly, constitutes news. Yesterday, Cell Therapeutics Inc. issued a release stating the FDA had “concluded that accelerated approval of...
View ArticleClik here to view.
The Good, the Bad and . . . the Huh? A 2011 Biotech Recap
The past year brought the biotech sector a mixed bag of news. Some of it was positive – for instance, the FDA picked up its drug approval pace in 2011 and, in some cases, even surprised the most...
View ArticleClik here to view.
He Said What?!?! Best Biotech Quotes of 2011
As BioWorld Insight readers know, our “Word on the Street” column provides a sample of the most entertaining and thought-provoking quotes our staff stumbles upon each week. Some are gathered during...
View ArticleClik here to view.
‘Fast’ Progress: Ampligen Activist Ends Hunger Strike
Robert Miller, the patient advocating for Hemispherx Biopharma Inc.’s Ampligen (rintatolimod) for chronic fatigue syndrome by going on a hunger strike in protest of the FDA’s complete response letter,...
View Article